Tatva Chintan: Stable Promoter Control Amidst High Valuation

Tatva Chintan Pharma Chem’s promoter group maintained a substantial and stable control, holding 72.02% of the company as of June 2026. This consistent ownership, unchanged since June 2025, signals no significant dilution by its founding members.

Key Shareholding Metrics

• Promoter Holding (June 2026): 72.02% (Consistent since June 2025)
• Shekhar Rasiklal Somani: 23.07%
• Chintan Nitinkumar Shah: 20.94%
• Ajay Mansukhlal Patel: 20.16%

Institutional participation within Tatva Chintan remains modest, although domestic institutional investors increased their stake to 0.32% by June 2026. Mutual funds held 2.79%, a decrease from previous quarters, while foreign institutional investors recorded 3.93%, showing a slight increase from March but a decline from December 2025.

Institutional & Notable Investors

• Nippon India Mutual Fund: 2.209% (Largest institutional holder)
• ICICI Prudential Mutual Fund: 0.529%
• Goldman Sachs Funds (Goldman Sachs India Equity Portfolio): 2.59%
• Nippon Life India Trustee Ltd (Nippon India ELSS Tax Saver Fund): 2.21%
• Mukul Mahavir Agrawal (Individual investor): 2.14%

Insider trading activity included a notable inter-se transfer on February 6, 2026. Ajay Mansukhlal Patel acquired 7,15,345 shares from Ajay Mansukhlal Patel HUF for ₹8,183.55 lakh, an internal transaction that did not alter the promoter family’s overall economic exposure.

Valuation Snapshot

• Market Capitalization (August 28, 2026): ₹3,829 crore
• Closing Share Price (August 28, 2026): ₹1,630
• Price-to-Earnings (P/E) Ratio: 74.5
• Price-to-Book (P/B) Ratio: 4.8

As of August 28, 2026, Tatva Chintan Pharma Chem shares closed at ₹1,630, reflecting a market capitalization of ₹3,829 crore. The company’s valuation is considered high, with a price-to-earnings ratio of 74.5 and a price-to-book ratio of 4.8. The concentrated ownership structure limits free-float dynamics, supporting management continuity but potentially constraining market liquidity and institutional influence. Investors should monitor future shareholding disclosures for shifts in institutional and foreign fund positions.